Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Find out which rewards program is best suited for your lifestyle and spending habits. Maximize your value with our expert insights!
22,671 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
The space-launch landscape is shifting as Blue Origin faces a setback. This could paradoxically amplify SpaceX's IPO ...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...
Rocket Lab isn’t profitable yet, but the space company shows four clear catalysts for investors. Here are practical r...
Meta Platforms’ AI push is reshaping sentiment around NVIDIA. This article breaks down what that means for NVIDIA sto...
Investors often chase the high yield offered by Alphabet's convertible preferred stock. This guide breaks down what t...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...
An AI model branded as WarrenAI outlines a bifurcated Bitcoin path for late 2026: a resilient floor around $50k-$55k ...
Archer’s Q1 2026 numbers set the tone for the year. This article breaks down the earnings call, explains what really ...
Kroger’s stock move today sparked questions about earnings, margins, and future guidance. This analysis breaks down w...
A significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
A new nationwide survey finds 39% of Americans store unused electronics in drawers, while only 10% are recycled or re...